18 November 2019 - BEAM Alliance

BEAM Alliance is releasing a new position paper on PULL Incentives: ‘Incentivising a sustainable response to the threat of AMR’

Without adequate incentives it is anticipated that in less than 2 years from now, many AMR SMEs will have disappeared…

12 April 2019 - BEAM Alliance

BEAM Alliance is proposing a new approach to foster better differentiation between antimicrobials: ‘A new vision for AMR innovation to support medical care’!

By linking a specific ATM to a specific step of the infectious process, novel clinical outcomes could be identified that…

25 March 2019 - BEAM Alliance

BEAM Alliance is releasing a new position paper on PUSH Incentives: ‘Supporting financial investments on R&D to de-risk antimicrobial development!’

The intention of this Memo is to provide different suggestions to help ensure that the R&D funding instruments (e.g. from…

18 November 2019 - BEAM Alliance

New BEAM Alliance Position Paper calls out stakeholders to rapidly provide market-based solutions supporting SME-driven innovation against antimicrobial resistance

The European BEAM Alliance, representing 72 ‘Biotech companies from Europe innovating in AntiMicrobial resistance research’, today released a position paper…

BEAM News
Member News
Events

Latest news of BEAM Alliance

03 December 2019 - BEAM Alliance

New IMI project “COMBINE” launched to accelerate the fight against antimicrobial resistance

The aim of the IMI Antimicrobial Resistance (AMR) Accelerator is to progress the development of new medicines to treat or…

18 November 2019 - BEAM Alliance

BEAM Alliance is releasing a new position paper on PULL Incentives: ‘Incentivising a sustainable response to the threat of AMR’

Without adequate incentives it is anticipated that in less than 2 years from now, many AMR SMEs will have disappeared…

18 November 2019 - BEAM Alliance

New BEAM Alliance Position Paper calls out stakeholders to rapidly provide market-based solutions supporting SME-driven innovation against antimicrobial resistance

The European BEAM Alliance, representing 72 ‘Biotech companies from Europe innovating in AntiMicrobial resistance research’, today released a position paper…

19 July 2019 - BEAM Alliance

BEAM Alliance: Time to give your feedback on how to characterize antimicrobial activity!

The BEAM Alliance proposed a six-way approach to characterize ATM activity, with the aim of opening new doors in the…

06 June 2019 - BEAM Alliance

Emergency on planet AMR: a vital pipeline to protect

The sooner we come up with practical solutions, the more SMEs (and currently developed products) we can save from vanishing.…

12 April 2019 - BEAM Alliance

BEAM Alliance is proposing a new approach to foster better differentiation between antimicrobials: ‘A new vision for AMR innovation to support medical care’!

By linking a specific ATM to a specific step of the infectious process, novel clinical outcomes could be identified that…

page 1/3

Tweets by alliancebeam

View twitter feed

Latest news of BEAM Members

07 January 2020 - Centauri Therapeutics Ltd

CARB-X backs Centauri to advance a new platform that combines antibiotic power with the ability to boost the immune system to fight infections caused by drug-resistant bacteria

The award will help Centauri continue the development of ABX01. The novel immunotherapy is in the lead optimization phase of…

06 January 2020 - Mutabilis SAS

Novo Holdings REPAIR Impact Fund Invests USD 12 million in Mutabilis and IBT Vaccines

Aleks Engel, Director of the REPAIR Impact Fund, commented: “We are thrilled to have Mutabilis and IBT Vaccines join the…

04 January 2020 - VetoPhage

Interview De VetoPhage, Labellisée French Tech Seed

Bacterial resistance to antibiotics is increasing dramatically both in animal health and in human health. So thanks to a “one…

02 January 2020 - ANTABIO S.A.S

Antabio Awarded $4.4 Million from CARB-X for the Further Development of its New Treatment for Pseudomonas aeruginosa Infections in Cystic Fibrosis Patients

Antabio’s innovative PEi program seeks to develop an inhaled product to be used as an adjunct to existing therapy and…

03 December 2019 - Grit42

New IMI project “COMBINE” launched to accelerate the fight against antimicrobial resistance

Co-founder and CEO of grit42, Claus Stie Kallesøe, adds, “The COMBINE project is an important milestone in the evolution of…

18 November 2019 - Grit42

Strengthening their commitment to help tackle antimicrobial resistance, grit42 joins the BEAM Alliance

“We’re thrilled to join the BEAM Alliance - the premier European network within the AMR community. As we’re already part…

page 1/16

Events

13 July 2020

Curious2020 – Future Insight

In 2020 the Future Insight Prize will be given out in the area of Multi Drug Resistance to enable a…

23 March 2020

BIO-Europe, 14th International Partnering Conference

BIO-Europe Spring attracts a wide range of business leaders, including senior executives of leading biotech companies, business development teams from…

27 February 2020

REVIVE Webinar: PK/PD murine infection models: Focus on study elements, variability, and interpretation of results

Topics discussed will include: - Understanding and embracing the inherent variability in many components of the murine model. - Demonstrating…

21 January 2020

REVIVE Webinar: Testing for the potential of emergence of resistance

This presentation was also part of the 'Bootcamp: Understanding the Potential for Antimicrobial Resistance in the Drug Discovery Process', jointly…

13 December 2019

JPIAMR Hacking AMR 2019

Finding digital solutions to fight Antimicrobial Resistance is our theme for this special international JPIAMR hackathon. The hackathon aim is…

05 December 2019

Life Sciences Series #1

The Ark Life Science Series #1 provides an excellent opportunity to exchange with representatives from all relevant sectors (pharmaceutical companies,…

26 November 2019

REVIVE Webinar: Innovation in point-of-care diagnostics for sepsis and bloodstream infections

In this webinar our moderator Caroline Purslow (Nesta Challenges) will welcome three speakers. Till Bachmann (University of Edinburgh) will give…

13 November 2019

Matchmaking Symposium ‘Emerging Antimicrobials and Diagnostics in AMR 2019’

The event provides an excellent podium for emerging Antimicrobials and Diagnostics as well as an exciting program including orchestrated matchmakings,…

07 November 2019

World Anti-Microbial Resistance Congress

The conference gathers global leaders in infectious diseases to meet, brainstorm and discuss the challenges and opportunities on seven topic…

page 1/4